Imgen BioSciences, Inc. (Imgen) is a biotechnology company. It is focused on the discovery and development of immunotherapeutic agents/techniques in the fields of cancer and infectious diseases.

News

Imgen's Founder and President Dr. Wendell Yang granted a first patent on TCR-CAR-T(Tcar-T) related technology in Australia. April, 2022 [PDF]

Imgen's Founder and President Dr. Wendell Yang’s PCT patent application on TCR-CAR-T(Tcar-T) related technology published. Jan., 2021 [PDF]

Imgen's Founder and President Dr. Wendell Yang as a first inventor granted another US patent on CAR-T related technology. Dec., 2020 [PDF]

Imgen's Founder and President Dr. Wendell Yang as a first inventor granted a US patent on CAR-T related technology. Dec., 2015 [PDF]

Biomanufacturing keeps moving along on SouthCoast. Sept., 2014 [PDF]

Imgen supports Massachusetts Life Sciences Center Internship 2013 [PDF]